Literature DB >> 16569883

In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis.

Visanu Thamlikitkul1, Suwanna Trakulsomboon.   

Abstract

Investigation of the in vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis revealed that the inhibition zone diameters of tigecycline against all isolates were >or=20 mm and that the MIC50 values were 0.5 and 1 microg/ml and the MIC90 values were 2 and 1.5 microg/ml for B. pseudomallei and B. thailandensis, respectively.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16569883      PMCID： PMC1426953          DOI： 10.1128/AAC.50.4.1555-1557.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Arabinose-positive Burkholderia pseudomallei infection in humans: case report.

Authors:  N Lertpatanasuwan; K Sermsri; A Petkaseam; S Trakulsomboon; V Thamlikitkul; Y Suputtamongkol
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

2.  Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods.

Authors:  T J J Inglis; F Rodrigues; P Rigby; R Norton; B J Currie
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.

Authors:  D A Dance; V Wuthiekanun; W Chaowagul; Y Suputtamongkol; N J White
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

4.  Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei.

Authors:  V Wuthiekanun; M D Smith; D A Dance; A L Walsh; T L Pitt; N J White
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

5.  Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains.

Authors:  P J Brett; D Deshazer; D E Woods
Journal:  Epidemiol Infect       Date:  1997-04       Impact factor: 2.451

Review 6.  The pharmacokinetic and pharmacodynamic profile of tigecycline.

Authors:  Alison K Meagher; Paul G Ambrose; Thaddeus H Grasela; Evelyn J Ellis-Grosse
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

7.  Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.

Authors:  A J Godfrey; S Wong; D A Dance; W Chaowagul; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 8.  The glycylcyclines: a comparative review with the tetracyclines.

Authors:  George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern Vercaigne; John Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

10.  Survival of Pseudomonas pseudomallei in human phagocytes.

Authors:  S Pruksachartvuthi; N Aswapokee; K Thankerngpol
Journal:  J Med Microbiol       Date:  1990-02       Impact factor: 2.472
View more
  5 in total

1.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

Review 2.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

Review 3.  Treatment and prophylaxis of melioidosis.

Authors:  David Dance
Journal:  Int J Antimicrob Agents       Date:  2014-02-03       Impact factor: 5.283

4.  Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents burkholderia mallei and burkholderia pseudomallei.

Authors:  Jacob Gilad; David Schwartz; Yoram Amsalem
Journal:  Int J Biomed Sci       Date:  2007-09

5.  The In Vitro Antibiotic Susceptibility of Malaysian Isolates of Burkholderia pseudomallei.

Authors:  Norazah Ahmad; Rohaidah Hashim; Azura Mohd Noor
Journal:  Int J Microbiol       Date:  2013-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.